Background Prevention of HIV transmission is fundamental to ending the HIV epidemic. Pre‐
exposure prophylaxis (PrEP) with oral tenofovir‐emtricitabine (TDF‐FTC) is an established …

After a decade of oral HIV pre-exposure prophylaxis (PrEP), the next generation of PrEP is
being anticipated, including long-acting pills, injections, and implants. The unevenness of …

Through the development and implementation of HIV pre-exposure prophylaxis (PrEP), the
characteristics of PrEP users have been configured in a range of ways. Drawing on the …

Stigma may influence the use of HIV pre-exposure prophylaxis (PrEP). However, there is an
absence of robust measures for PrEP-related stigma. We describe an adaptation of a HIV …

While sub-Saharan African migrants are recognized as a key population in the HIV
epidemics, they are absent from the PrEP delivery system and in particular women. The …

Women in the USA represent 15% of new HIV diagnoses but only 5% of pre-exposure
prophylaxis (PrEP) users. We sought to characterise communicative appeals and …

This study examined the discourses of gay and bisexual men who seek Party-n-Play (PNP;
sex that occurs under the influence of drugs) on mobile apps and websites. In-depth …

After nearly a decade of HIV pre-exposure prophylaxis (PrEP) rollout in sub-Saharan Africa,
there has been limited study of PrEP messaging in news media. We selected twenty South …

The introduction of pre-exposure prophylaxis (PrEP) in 2012 in the US ushered in new
technology for preventing HIV in people who are seen as at risk of contracting HIV. However …

Quelques années après sa mise sur le marché, on réalise que la PrEP (la prophylaxie pré-
exposition) touche peu de monde, y compris dans le Nord global qui est son lieu principal …